The Role of C-HAM in the Surgical Repair of Peroneal Tendons: An Infrared Thermography Model (Amniox)

September 29, 2016 updated by: Greg Berlet, Orthopedic Foot and Ankle Center, Ohio

The Role of Cryopreserved Human Amniotic Membrane in the Surgical Repair of Peroneal Tendons: An Infrared Thermography Model

Peroneal tendon tears are a common etiology encountered by foot and ankle surgeons. Like all flexor tendon repairs adhesions are one of the more common challenges after surgery. Peroneal tendon gliding is key to their function as effective plantar flexors and evertors of the hindfoot. Scarring and adhesion correlate directly with the amount of inflammatory reaction at the wound site (Adzick 1994). Our goal is to have a surgical technique that allows for standard suture repair of the tendon yet allows for smooth gliding of the tendon with minimal adhesions. A prospective review on the surgical repair of the peroneal tendons utilizing Clarix™1k (Amniox Medical, Marietta, GA), cryopreserved Human Amniotic Membrane (C-HAM) graft will be performed. The investigators hypothesize that the use of cryopreserved Human Amniotic Membrane in conjunction with a peroneal tendon repair will decrease that amount of inflammation, overall recovery time of surgically repaired peroneal tendon tears, and adhesions.

Study Overview

Status

Terminated

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

2

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Ohio
      • Westerville, Ohio, United States, 43082
        • Orthopedic Foot and Ankle Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. Patients requiring surgical repair of the peroneal tendon
  2. Patients who voluntarily consent to research participation
  3. Patients over the age of 18

Exclusion Criteria:

  1. Patients who display a high surgical risk as determined by the investigative surgeon
  2. Previous surgical repair of the peroneal tendon less than 2 years prior to surgery
  3. Peroneus brevis tears in zone 3 or 4 that may hinder recovery in the investigator's opinion
  4. Patients with allergy or history of drug reactions to Ciprofloxacin or Amphotericin B
  5. Patients who are pregnant or breast feeding.
  6. Patients who have had a clinically diagnosed autoimmune disease
  7. Patients who are unwilling to restrict pre and postoperative anti-inflammatories with the exception of ecotrin 325 mg QD for DVT prophylaxis during the postoperative immobilization period
  8. Patients with an active infection
  9. Patients who have a medical history that would likely make the patient an unreliable research participant
  10. Patients requiring surgical repair of the peroneus longus tendon

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Clarix™1k graft
Group 1 will have standard peroneal repair surgery with the addition of the Clarix™1k tissue.

Group 1 will have standard peroneal repair surgery with the addition of the Clarix™1k tissue.

Group 2 will have standard peroneal repair surgery without the use of the Clarix™1k tissue.

Other Names:
  • cryopreserved Human Amniotic Membrane (C-HAM) graft
No Intervention: Control arm without Clarix™1k graft
Group 2 will have standard peroneal repair surgery without the use of the Clarix™1k tissue.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Ankle Pain, Inflammation, Function & Activity Limitation From Baseline to 12 Months
Time Frame: Baseline,12 months

Ankle pain measured via visual analog scale (VAS), function measured by American Orthopaedic Foot and Ankle Society (AOFAS) ankle hindfoot scale and Foot Function Index (FFI), activity limitation measured by AOFAS scale. Images taken via thermal camera to measure inflammation were not interpretable.

VAS pain scale: 0-100, with a lower number representing a better score FFI scale: 0-100, with a lower number representing a better score AOFAS scale: 0-100, with a higher number representing a better score

Baseline,12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Gregory C Berlet, MD, Orthopedic Foot and Ankle Center

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

October 1, 2012

Primary Completion (Actual)

November 1, 2014

Study Completion (Actual)

November 1, 2014

Study Registration Dates

First Submitted

September 5, 2012

First Submitted That Met QC Criteria

October 15, 2012

First Posted (Estimate)

October 16, 2012

Study Record Updates

Last Update Posted (Estimate)

November 3, 2016

Last Update Submitted That Met QC Criteria

September 29, 2016

Last Verified

September 1, 2016

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • OH1-12-00396

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Tendon Tears

Clinical Trials on Clarix™1k graft

Subscribe